Filter Results:
(5,814)
Show Results For
- All HBS Web
(5,814)
- People (4)
- News (1,259)
- Research (3,435)
- Events (83)
- Multimedia (192)
- Faculty Publications (2,849)
Show Results For
- All HBS Web
(5,814)
- People (4)
- News (1,259)
- Research (3,435)
- Events (83)
- Multimedia (192)
- Faculty Publications (2,849)
- April 2025
- Teaching Note
ZEISS: Commercializing Science
By: Maria P. Roche
Teaching Note for HBS Case No. 725-359. View Details
Keywords: Business Model; Business Organization; Decisions; Business Strategy; Competition; Business History; Collaborative Innovation and Invention; Independent Innovation and Invention; Disruptive Innovation; Innovation and Management; Innovation Strategy; Technological Innovation; Growth and Development Strategy; Knowledge Sharing; Industry Growth; Monopoly; Organizational Culture; Supply Chain Management; Partners and Partnerships; Risk and Uncertainty; Adaptation; Commercialization; Resource Allocation; Corporate Strategy; Semiconductor Industry; Technology Industry; Germany; Europe
- July 2024
- Case
ZEISS: Commercializing Science
By: Maria P. Roche, Carlota Moniz and Daniela Beyersdorfer
Karl Lamprecht, President and CEO of the ZEISS AG Group, mused on how far ZEISS had come in 175 years of being a pioneer in optics, and how the course he had charted since taking the helm of the company could keep it on track. In his role, he oversaw the four core... View Details
Keywords: Business Model; Business Organization; Decisions; Business Strategy; Competition; Business History; Collaborative Innovation and Invention; Independent Innovation and Invention; Disruptive Innovation; Innovation and Management; Innovation Strategy; Technological Innovation; Growth and Development Strategy; Knowledge Sharing; Industry Growth; Monopoly; Organizational Culture; Supply Chain Management; Partners and Partnerships; Risk and Uncertainty; Adaptation; Commercialization; Resource Allocation; Corporate Strategy; Semiconductor Industry; Technology Industry; Germany; Europe
Roche, Maria P., Carlota Moniz, and Daniela Beyersdorfer. "ZEISS: Commercializing Science." Harvard Business School Case 725-359, July 2024.
- November 1974 (Revised May 1994)
- Case
Science Technology Co.
By: Thomas R. Piper
The president of a medium-sized electronics company is evaluating the financial forecasts and proposed financing program submitted by the chief financial officer. The forecasts are prepared in constant dollars, on which basis the proposed financing plan seems... View Details
Keywords: Currency; Financial Strategy; Forecasting and Prediction; Inflation and Deflation; Risk and Uncertainty; Outcome or Result; Technology Industry; Electronics Industry
Piper, Thomas R. "Science Technology Co." Harvard Business School Case 275-058, November 1974. (Revised May 1994.)
- May 2020
- Teaching Note
Bayer Crop Science
By: David E. Bell, Michael Norris and Mel Martin
Teaching Note for HBS Case No. 520-055. View Details
- October 2022
- Supplement
Single Earth: Science White Paper Supplement
By: Rembrand Koning and Emer Moloney
Science White Paper prepared by Single.Earth to give an overview of the models and solutions it has developed. View Details
Keywords: Business Startups; Entrepreneurship; Climate Change; Environmental Sustainability; Green Technology; Natural Resources; Pollution; Analytics and Data Science; Marketing; Product Marketing; Product Launch; Product Positioning; Markets; Market Timing; Strategy; Green Technology Industry; Estonia
- Fall 2012
- Article
Climate Science as Culture War
By: Andrew J. Hoffman
Today, there is no doubt that a scientific consensus exists on the issue of climate change. Scientists have documented that anthropogenic sources of greenhouse gases are leading to a buildup in the atmosphere, which leads to a general warming of the global climate and... View Details
Hoffman, Andrew J. "Climate Science as Culture War." Stanford Social Innovation Review 10, no. 4 (Fall 2012): 30–37. (Winner of the 2013 Maggie Climate science as culture war Award, Best Feature Article in a Trade Journal.)
- February 1989 (Revised November 1991)
- Case
Science Technology Co.--1985
By: Thomas R. Piper
The CEO of a U.S. electronics firm is assessing the financial forecasts and the financing plan prepared by the chief financial officer. Given the cyclicality of the industry and the volatility of the firm's performance, the CEO is unsure as to the usefulness of... View Details
Keywords: Risk and Uncertainty; Change Management; Industry Growth; Forecasting and Prediction; Financial Strategy; Volatility; Electronics Industry
Piper, Thomas R. "Science Technology Co.--1985." Harvard Business School Case 289-040, February 1989. (Revised November 1991.)
- December 2020
- Supplement
VIA Science (B)
By: Juan Alcácer, Rembrand Koning, Annelena Lobb and Kerry Herman
Via (a) captures the early days of the data analytics startup as founders Gounden and Ravanis considered which markets offer the right opportunities for their firm and what kinds of experiments will help them narrow their choice. Supplement Via (b) reveals the... View Details
Keywords: Data Analytics; Machine Learning; Artificial Intelligence; Strategy; Business Startups; AI and Machine Learning; Telecommunications Industry; Utilities Industry; United States; Japan
Alcácer, Juan, Rembrand Koning, Annelena Lobb, and Kerry Herman. "VIA Science (B)." Harvard Business School Supplement 721-368, December 2020.
- 17 Jun 2014
- News
Rebooting Social Science
- 07 Dec 2010
- News
Social Science Palooza
- 28 Apr 2021
- HBS Conference
Strategy Science Conference
- 25 Jun 2019
- Blog Post
Learning the Language of Business and Science – The MS/MBA Biotechnology: Life Sciences Program
misalignments can lead to inefficiencies that waste money and slow the development of important treatments. While the science-business gap in biotechnology poses a significant challenge, it also presents an opportunity. Professionals who understand the language of... View Details
- 13 Nov 2006
- Research & Ideas
Science Business: What Happened to Biotech?
sector has lost money during this period, new research shows. What went wrong? Professor Gary Pisano provides answers in the new book Science Business: The Promise, the Reality, and the Future of Biotech, in which he argues that the very... View Details
- April 13, 2021
- Article
Misinformation about Science in the Public Sphere
By: Dietram A. Scheufele, Andrew J. Hoffman, Liz Neely and Czerne M. Reid
This is an introduction to a special issue on a colloquium of the National Academies of Sciences, Engineering, and Medicine titled, “Advancing the science and practice of science communication: Misinformation about science in the public sphere.” This event was the... View Details
Scheufele, Dietram A., Andrew J. Hoffman, Liz Neely, and Czerne M. Reid. "Misinformation about Science in the Public Sphere." Proceedings of the National Academy of Sciences 118, no. 15 (April 13, 2021).
- 15 Nov 2023
- Video
The Science of Failing Well
- 23 Jul 2019
- Video
MS/MBA Biotechnology: Life Sciences Webinar
- August 1997
- Case
Orbital Sciences Corporation: ORBCOMM
By: Das Narayandas and John A. Quelch
In late 1993, Orbital Communications Corp. (OCC), a subsidiary of Orbital Sciences Corp., is developing a global two-way wireless data communications system, called "ORBCOMM," based on a 26-satellite constellation in low earth orbit. Service is scheduled to begin in... View Details
Keywords: Business Subsidiaries; Business Model; Business Startups; Price; Global Strategy; Marketing Strategy; Demand and Consumers; Partners and Partnerships; Salesforce Management; Telecommunications Industry
Narayandas, Das, and John A. Quelch. "Orbital Sciences Corporation: ORBCOMM." Harvard Business School Case 598-027, August 1997.
- April 2021
- Supplement
VIA Science (C)
By: Juan Alcácer, Rembrand Koning, Annelena Lobb and Kerry Herman
Alcácer, Juan, Rembrand Koning, Annelena Lobb, and Kerry Herman. "VIA Science (C)." Harvard Business School Supplement 721-372, April 2021.
- 06 Dec 2021
- News
Vision: Sound Science
It was a milestone to celebrate: Earlier this year, designations from FDA and European Union regulators moved researchers at the Boston-based startup Akouos, Inc., a step closer to producing the first-ever therapy for gene-mediated hearing loss. The product could... View Details
Keywords: Deb Blagg